Not really. Yes Novartis theranostic programs in prostate and other cancers, but the isotopes used are different as well as the ligands. Copper really is the "perfect pair" as Alan loves to point out all the time. While it is great to be first in class, being best in class is pretty great too.
In my opinion the real value of CU6 is the scalability of Cu64/Cu67. I foresee CU6 being acquired by a large sooner rather than later although I would like to see CU6 get as far as they can before this happens.
Ann: Northstar Achieves Key Production Milestones, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.89 |
Change
0.040(0.68%) |
Mkt cap ! $1.835B | |||
| Open | High | Low | Value | Volume |
| $5.98 | $6.08 | $5.74 | $6.370M | 1.086M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3474 | $5.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.90 | 825 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |